CTLA4 and neoplasm: According to recent studies, ferroptosis can regulate the anticancer activity of CD8+ T cells via increasing tumor cell sensitivity to PD-1/PD-L1 or CTLA-4 blocking therapy (Lang et al., 2019; Wang et al., 2019).